FOXP3 and cancer: FoxP3+ Treg cells with an activated phenotype can be enriched in tumors in comparison with peripheral blood and are associated with a poor prognosis in patients with various types of cancer, including cervical, renal, melanomas, and breast cancers (83, 84).